|
|
HAPPY PRIDE MONTH!
June is Pride Month in recognition and celebration of the LGBTQIA+ community. If you are interested in HIV prevention, treatment, and care in this community, we invite you to join the DC CFAR Sexual and Gender Minorities Scientific Interest Group by contacting Allison O’Rourke. Please see upcoming events in DC on the Capital Pride Alliance website here. We invite members of the DC CFAR community to send information about any additional events and activities to CFARinDC@gmail.com. |
|
DC CFAR HIV Cure SWG Lead Dr. Rebecca Lynch Promoted to Associate Professor with Tenure |
|
Please join us in congratulating Dr. Rebecca Lynch on her promotion to the rank of Associate Professor with tenure in the Department of Microbiology, Immunology, and Tropical Medicine in the School of Medicine and Health Sciences at GW. As the Academic lead of the DC CFAR HIV Cure Scientific Working Group, Dr. Lynch aims to explore these paths by discovering and supporting new collaborations cross-institutionally and emphasizing community-focused research. She currently serves as the PI for three NIH-funded projects including an R01 entitled "Quantifying the fitness cost of HIV-1 resistance to broadly neutralizing antibodies", R61 (MPI) entitled "Ultrasensitive Env Detection Assay for Broadly Neutralizing Antibody Screening" and U01 (MPI) entitled "Complementing broadly neutralizing antibodies and autologous responses to restrict virus escape and durably suppress HIV-1" and as a collaborator in several other NIH grants. |
|
Join the Next DC CFAR SBS Core June Writing Retreat |
Please join the DC CFAR Social and Behavioral Sciences Core June Writing Retreat on Friday, June 16th from 12 to 2 pm ET. The writing retreat will follow the below format:
- 10-minute brief introductions and goal sharing
- 40-minute writing block
- 10-15-minute break
- 40-minute writing block
- 15-minute debrief and progress sharing
This is an excellent opportunity for Investigators working on an existing project or starting a new one, to help carve out time in their work calendar. If you have any questions, please contact Wendy Davis or Allison O’Rourke.
Please click here for more information on how to join this session.
|
|
New Publication on "Targeted Social Marketing of PrEP and the Stigmatization of Black Sexual Minority Men" |
DC CFAR Pilot Award Recipient Dr. Sarah Calabrese (GW) with DC CFAR Co-Director Dr. Manya Magnus (GW), Cure SWG Co-lead Mr. Riko Boone (TAG), and SBS Core Co-Director Dr. Maria Cecilia Zea (GW) and colleagues published an article in the Journal of PLOS ONE in May 2023 entitled " Targeted social marketing of PrEP and the stigmatization of black sexual minority men".The authors conducted a mixed methods study to understand Black sexual minority men's response to target PrEP advertisements. This publication builds from Dr. Calabrese's DC CFAR Pilot project titled "Optimizing PrEP Social Marketing to Black MSM in DC to Raise Awareness and Uptake".
Please click here to read the article.
|
|
|
New Publication on Barriers and Facilitators to Culturally Responsive HIV and PrEP Screening |
Please click here to read the article.
|
|
HOLD THE DATE - DC CFAR Scientific Symposium, October 10 |
The DC CFAR is proud to announce the Return of the DC CFAR Scientific Symposium – 2023! The symposium will be held on Tuesday, October 10 from 9:30 am-3:30 pm in the GW Milken Institute School of Public Health Convening Center. This will be the first CFAR-wide event that we have held in person since the onset of the pandemic, and we are greatly looking forward to bringing the DC HIV community together once again for this exciting symposium.
We will soon begin inviting speakers and planning the logistics for the symposium, but we wanted to notify you now so that you can HOLD THIS DATE on your calendars. We are grateful for your continued support of and engagement with the DC CFAR!
|
|
|
Do you have an event you would like to see included in the next edition of the Community Spotlight? We invite any news or updates from the DC CFAR community and encourage you to send information that may be of interest to CFARinDC@gmail.com. |
|
Below you will find several resources of interest developed and gathered by DC CFAR partner institutions and community-based organizations. We encourage you to send information that may be of interest to our DC CFAR community to CFARinDC@gmail.com.
|
|
DC CFAR partner institutions and community-based organizations have developed numerous excellent COVID-19 resources. We've included a collection of these here, along with a number of other opportunities for your reference. We will continue to update these resources in the days ahead and we encourage you to send information that may be of interest to our DC CFAR community to CFARinDC@gmail.com.
|
|
June 9, 2023
June 13, 2023
June 14, 2023
June 15, 2023
June 15, 2023
June 15-16, 2023
June 16, 2023
June 16, 2023
June 19, 2023
June 22, 2023
June 26, 2023
June 28, 2023
June 28-29, 2023
June 29, 2023
July 10-21, 2023
July 11, 2023
July 23-26, 2023
Brisbane, Australia
July 22, 2023
Brisbane, Australia
July 31-August 4, 2023
Boulder, Colorado
August 7-11, 2023
Bethesda, Maryland
August 15, 2023
August 20-23, 2024
For more DC CFAR events please see the calendar here.
|
|
FUNDING, TRAINING AND MENTORING OPPORTUNITIES
|
|
The National Institute of Mental Health (NIMH) is issuing a NOSI focused on implementation research, for applications designed in partnership with domestic and global service providers to advance HIV prevention and treatment goals (domestically) or targets (globally).
The National Institute of Mental Health (NIMH) is issuing a NOSI focused on understanding and addressing the impact of mental health comorbidities, including mental health disorders, violence, and trauma, on HIV prevention and treatment outcomes.
Join on July 10-11 a grant writing workshop hosted by the Department of Pharmaceutical Sciences, College of Pharmacy, Howard University. This free in-person workshop is for faculty, postdocs, and research development professionals interested in pursuing NIH funding for their research.
Avant-Garde and Avenir Awards
These NIDA HIV research programs award funds to investigators planning high-impact research projects focused on the prevention and treatment of HIV/AIDS among people who use drugs. Avant is for groundbreaking researchers at all levels of their careers and Avenir focuses on early-stage investigators. Applications period July 15-August 15, 2023.
The U.S. Military HIV Research Program (MHRP) at the Walter Reed Army Institute of Research (WRAIR) and collaborators recently launched a Phase 1 trial that will evaluate safety, tolerability, and immunogenicity of varying doses of the Army’s novel ALFQ adjuvant in a candidate HIV vaccine to optimize adjuvant dosage. For more information including eligibility, please see the flyer here.
The Substance Abuse and Mental Health Services Administration (SAMHSA) is offering a funding opportunity to support substance use and HIV prevention services for racial and ethnic minority populations at high-risk for substance use disorders (SUDs) and HIV infection. Applications are due June 20.
|
|
NIH FUNDING OPPORTUNITIES
|
|
Funding Opportunity Number: PAR-23-206
Posting Date: June 2, 2023
Closing Date: September 13, 2023
Funding Opportunity Number: PAR-23-190
Posting Date: May 10, 2023
Closing Date: December 20, 2023
Funding Opportunity Number: PAR-23-191
Posting Date: May 10, 2023
Closing Date: December 8, 2023
Funding Opportunity Number: PAR-23-169
Posting Date: April 21, 2023
Closing Date: August 2, 2023
Funding Opportunity Number: RFA-AI-23-026
Posting Date: April 21, 2023
Closing Date: August 2, 2023
Funding Opportunity Number: RFA-AI-23-023
Posting Date: April 14, 2023
Closing Date: August 2, 2023
Click here for additional funding opportunities available from the National Institutes of Health.
|
|
The DC CFAR is an NIH funded program (P30AI117970), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NIDCR, NHLBI, NIDA, NIMH, NIA, NIDDK, NINR, NIMHD, FIC, and OAR. The content isthe responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. |
|
|
|
|
|
|
|
|
